BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31119158)

  • 1. The Nutritional Cytokine Leptin Promotes NSCLC by Activating the PI3K/AKT and MAPK/ERK Pathways in NSCLC Cells in a Paracrine Manner.
    Li F; Zhao S; Guo T; Li J; Gu C
    Biomed Res Int; 2019; 2019():2585743. PubMed ID: 31119158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Associated Fibroblasts Accelerate Malignant Progression of Non-Small Cell Lung Cancer via Connexin 43-Formed Unidirectional Gap Junctional Intercellular Communication.
    Luo M; Luo Y; Mao N; Huang G; Teng C; Wang H; Wu J; Liao X; Yang J
    Cell Physiol Biochem; 2018; 51(1):315-336. PubMed ID: 30453281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling.
    Zhou Z; Zhou Q; Wu X; Xu S; Hu X; Tao X; Li B; Peng J; Li D; Shen L; Cao Y; Yang L
    Cancer Lett; 2020 Mar; 473():62-73. PubMed ID: 31904479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in SMAD3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer.
    Han F; Chen S; Zhang K; Zhang K; Wang M; Wang P
    J Transl Med; 2024 Mar; 22(1):288. PubMed ID: 38493128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of CCL20 from lung cancer cells induces the cell migration and proliferation through PI3K pathway.
    Wang B; Shi L; Sun X; Wang L; Wang X; Chen C
    J Cell Mol Med; 2016 May; 20(5):920-9. PubMed ID: 26968871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer.
    Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S
    J Mol Med (Berl); 2023 Dec; 101(12):1603-1614. PubMed ID: 37831111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
    Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
    Chen C; Chang YC; Lan MS; Breslin M
    Int J Oncol; 2013 Mar; 42(3):1113-9. PubMed ID: 23354006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HGF derived from cancer‑associated fibroblasts promotes vascularization in gastric cancer via PI3K/AKT and ERK1/2 signaling.
    Ding X; Xi W; Ji J; Cai Q; Jiang J; Shi M; Yu Y; Zhu Z; Zhang J
    Oncol Rep; 2018 Aug; 40(2):1185-1195. PubMed ID: 29917165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
    Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
    J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells.
    Xie X; Zu X; Laster K; Dong Z; Kim DJ
    J Pharmacol Sci; 2021 Mar; 145(3):279-288. PubMed ID: 33602509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
    Liu X; Sun L; Zhang S; Zhang S; Li W
    J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways.
    Hu H; Wang F; Wang M; Liu Y; Wu H; Chen X; Lin Q
    Int J Med Sci; 2020; 17(6):807-814. PubMed ID: 32218702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling.
    Zhao H; Wang Y; Ren X
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31123168
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
    Heits N; Heinze T; Bernsmeier A; Kerber J; Hauser C; Becker T; Kalthoff H; Egberts JH; Braun F
    BMC Cancer; 2016 May; 16():322. PubMed ID: 27206490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte and Adipokines Promote a Uterine Leiomyoma Friendly Microenvironment.
    Afrin S; Ramaiyer M; Begum UAM; Borahay MA
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.